Authors:
Poeggeler, B
Miravalle, L
Zagorski, MG
Wisniewski, T
Chyan, YJ
Zhang, YB
Shao, HY
Bryant-Thomas, T
Vidal, R
Frangione, B
Ghiso, J
Pappolla, MA
Citation: B. Poeggeler et al., Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid A beta peptide, BIOCHEM, 40(49), 2001, pp. 14995-15001
Citation: Yb. Zhang et al., Solution structure of the E200K variant of human prion protein - Implications for the mechanism of pathogenesis in familial prion diseases, J BIOL CHEM, 275(43), 2000, pp. 33650-33654
Citation: Hy. Shao et al., Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease, J MOL BIOL, 285(2), 1999, pp. 755-773
Authors:
Ma, K
Clancy, EL
Zhang, YB
Ray, DG
Wollenberg, K
Zagorski, MG
Citation: K. Ma et al., Residue-specific pK(a) measurements of the beta-peptide and mechanism of pH-induced amyloid formation, J AM CHEM S, 121(38), 1999, pp. 8698-8706
Authors:
Pappolla, MA
Chyan, YJ
Bozner, P
Soto, C
Shao, H
Reiter, RJ
Brewer, G
Robakis, NK
Zagorski, MG
Frangione, B
Ghiso, J
Citation: Ma. Pappolla et al., Dual anti-amyloidogenic and antioxidant properties of melatonin: A new therapy for Alzheimer's disease?, ALZHEIMER'S DISEASE AND RELATED DISORDERS, 1999, pp. 661-669